MCK Q3 2022 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q3 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$68.6B+9.6% YoY

Gross Profit

$3.3B4.8% margin

Operating Income

$323M0.5% margin

Net Income

-$7M-0.0% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+3.1%

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.3B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$63.7B

Total Liabilities

$64.5B

Stockholders' Equity

-$1.3B

Cash & Equivalents

$2.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68.6B	$62.6B	+9.6%
Gross Profit	$3.3B	$3.0B	+10.1%
Operating Income	$323M	$894M	-63.9%
Net Income	-$7M	-$6.2B	+99.9%

Revenue Segments

U.S. Pharmaceutical Segment

$55.0B80%

International Segment

$9.5B14%

Medical-Surgical Solutions Segment

$3.1B4%

Prescription Technology Solutions

$1.0B2%